{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:04:31Z","timestamp":1782572671890,"version":"3.54.5"},"reference-count":25,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2025,8,31]]},"DOI":"10.5582\/ddt.2025.01047","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T22:07:36Z","timestamp":1756159656000},"page":"230-236","source":"Crossref","is-referenced-by-count":1,"title":["Bovine lactoferrin intake prevents hepatic injury in a mouse model of non-alcoholic steatohepatitis induced by choline and methionine deficiency"],"prefix":"10.5582","volume":"19","author":[{"given":"Ryoken","family":"Aoki","sequence":"first","affiliation":[{"name":"Department of Functional Brain Activities, United Graduate School of Child Development, Osaka University, Osaka, Japan."},{"name":"Center for Pharmaceutical Education, Yokohama University of Pharmacy, Kanagawa, Japan."},{"name":"Research Center for Child Mental Development, University of Fukui, Fukui, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ishido","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Analysis, Yokohama University of Pharmacy, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Nozaki","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neon","family":"Ito","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Toho","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pharmaceutics, Yokohama University of Pharmacy, Kanagawa, Japan."},{"name":"General Health Medical Research Center, Yokohama University of Pharmacy, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Izumo","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacotherapy, Yokohama University of Pharmacy, Kanagawa, Japan."},{"name":"General Health Medical Research Center, Yokohama University of Pharmacy, Kanagawa, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, Swain MG, Congly SE, Kaplan GG, Shaheen AA. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022; 7:851-861.","DOI":"10.1016\/S2468-1253(22)00165-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults: Systematic review: epidemiology of NAFLD and NASH. Aliment Pharmacol Ther. 2011; 34:274-285.","DOI":"10.1111\/j.1365-2036.2011.04724.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Li J, Zou B, Yeo YH, <i>et al<\/i>. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019; 4:389-398.","DOI":"10.1016\/S2468-1253(19)30039-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Guo X, Yin X, Liu Z, Wang J. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. Int J Mol Sci. 2022; 23:15489.","DOI":"10.3390\/ijms232415489"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Terrault NA, Francoz C, Berenguer M, Charlton M, Heimbach J. Liver transplantation 2023: status report, current and future challenges. Clin Gastroenterol Hepatol. 2023; 21:2150-2166.","DOI":"10.1016\/j.cgh.2023.04.005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, Ito T, Katsume A, Sudoh M. An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol. 2013; 94:93-103.","DOI":"10.1111\/iep.12008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Vance DE. Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis. Curr Opin Lipidol. 2008; 19:229-234.","DOI":"10.1097\/MOL.0b013e3282fee935"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Li Q, Tan Y, Chen S, Xiao X, Zhang M, Wu Q, Dong M. Irisin alleviates LPS-induced liver injury and inflammation through inhibition of NLRP3 inflammasome and NF-\u03baB signaling. J Recept Signal Transduct Res. 2021; 41:294-303.","DOI":"10.1080\/10799893.2020.1808675"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Telang S. Lactoferrin: a critical player in neonatal host defense. Nutrients. 2018; 10:1228.","DOI":"10.3390\/nu10091228"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Liang L, Wang ZJ, Ye G, Tang XY, Zhang YY, Kong JX, Du HH. Distribution of lactoferrin is related with dynamics of neutrophils in bacterial infected mice intestine. Molecules. 2020; 25:1496.","DOI":"10.3390\/molecules25071496"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nielsen SM, Hansen GH, Danielsen EM. Lactoferrin targets T cells in the small intestine. J Gastroenterol. 2010; 45:1121-1128.","DOI":"10.1007\/s00535-010-0271-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fan F, Shi P, Liu M, Chen H, Tu M, Lu W, Du M. Lactoferrin preserves bone homeostasis by regulating the RANKL\/RANK\/OPG pathway of osteoimmunology. Food Funct. 2018; 9:2653-2660.","DOI":"10.1039\/C8FO00303C"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Yin H, Cheng L, Holt M, Hail N, Maclaren R, Ju C. Lactoferrin protects against acetaminophen-induced liver injury in mice. Hepatology. 2010; 51:1007-1016.","DOI":"10.1002\/hep.23476"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sugiyama A, Sato A, Takeuchi T. PEGylated lactoferrin enhanced its hepatoprotective effects on acute liver injury induced by carbon tetrachloride in rats. Food Chem Toxicol. 2009; 47:1453-1458.","DOI":"10.1016\/j.fct.2009.03.030"},{"key":"15","unstructured":"15. Honma K, Izumo N, Furukawa M, Miyazaki M, Sakurai J, Kuwahara Y, Kagaya S, Hoshino T, Watanabe Y. Effect of lactoferrin on non-alcoholic fatty liver in obese mice. Pharmacometrics. 2019; 96:93-99."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Suzuki N, Murakoshi M, Ono T, Morishita S, Koide M, Bae MJ, Totsuka M, Shimizu M, Sugiyama K, Nishino H, Iida N. Effects of enteric-coated lactoferrin tablets containing <i>Lactobacillus brevis<\/i> subsp. <i>Coagulans<\/i> on fecal properties, defecation frequency and intestinal microbiota of Japanese women with a tendency for constipation: a randomized placebo-controlled crossover study. Biosci Microbiota Food Health. 2013; 32:13-21.","DOI":"10.12938\/bmfh.32.13"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ganguly S, Muench GA, Shang L, <i>et al<\/i>. Nonalcoholic steatohepatitis and HCC in a hyperphagic mouse accelerated by Western diet. Cell Mol Gastroenterol Hepatol. 2021; 12:891-920.","DOI":"10.1016\/j.jcmgh.2021.05.010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hwang S-A, Kruzel ML, Actor JK. Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS. Tuberculosis (Edinb). 2016; 101S:S53-S62.","DOI":"10.1016\/j.tube.2016.09.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Moreno-Fierros L, Garc\u00eda-Hern\u00e1ndez AL, Ilhuicatzi-Alvarado D, Rivera-Santiago L, Torres-Mart\u00ednez M, Rubio-Infante N, Legorreta-Herrera M. Cry1Ac protoxin from <i>Bacillus thuringiensis<\/i> promotes macrophage activation by upregulating CD80 and CD86 and by inducing IL-6, MCP-1 and TNF-\u03b1 cytokines. Int Immunopharmacol. 2013; 17:1051-1066.","DOI":"10.1016\/j.intimp.2013.10.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Vega-Bautista A, de la Garza M, Carrero JC, Campos- Rodr\u00edguez R, God\u00ednez-Victoria M, Drago-Serrano ME. The impact of lactoferrin on the growth of intestinal inhabitant bacteria. Int J Mol Sci. 2019; 20:4707.","DOI":"10.3390\/ijms20194707"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shi H, Xu W, Liu Q, Li Y, Dong S, Zhao Z. AKR7A5 knockout promote acute liver injury by inducing inflammatory response, oxidative stress and apoptosis in mice. J Cell Mol Med. 2024; 28:e70129.","DOI":"10.1111\/jcmm.70129"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ha SK, Chae C. Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity. Exp Anim. 2010; 59:595-604.","DOI":"10.1538\/expanim.59.595"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mgbemena V, Segovia J, Chang TH, Bose S. KLF6 and iNOS regulates apoptosis during respiratory syncytial virus infection. Cell Immunol. 2013; 283:1-7.","DOI":"10.1016\/j.cellimm.2013.06.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Abdelmoneem MA, Elnaggar MA, Hammady RS, Kamel SM, Helmy MW, Abdulkader MA, Zaky A, Fang JY, Elkhodairy KA, Elzoghby AO. Dual-targeted lactoferrin shell-oily core nanocapsules for synergistic targeted\/herbal therapy of hepatocellular carcinoma. ACS Appl Mater Interfaces. 2019; 11:26731-26744.","DOI":"10.1021\/acsami.9b10164"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 2001; 480-481:243-268.","DOI":"10.1016\/S0027-5107(01)00183-X"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/4\/19_2025.01047\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T04:23:13Z","timestamp":1758342193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/4\/19_2025.01047\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2025.01047","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"article-number":"2025.01047"}}